We live and breathe science. 

Led by scientists, Elcella is a company driven by curiosity to improve the lives of all people. That is why all our research is focused on humans.

Our data comes from experiments performed on gut samples from real people who, just like us, want to help others.

Elcella is proud to be a company that values science and knowledge so we can bring you the best gut health solutions.

Founder & Chief Executive Officer

Dr. Madusha Peiris, PhD

Dr. Madusha Peiris completed her PhD at the University of Queensland, Australia. Her passion for understanding the gut-brain connection and the important role of nutrients in appetite regulation led to groundbreaking research. Dr. Madusha's dedication to her work was instrumental in the discovery that laid the foundation for Elcella’s natural approach to appetite control and digestive well-being.

Co-Founder & Chief Operating Officer

Dr. Ruby Aktar, PhD

Dr. Ruby Aktar completed her undergraduate studies at Queen Mary University of London, followed by a PhD in enteric neuroscience. Her research explores how gut microbes affect gut physiology, and how nutrients affect appetite regulation. Dr. Ruby is passionate about learning how to make natural supplements (like Elcella!), that manage appetite and improve overall well-being.

2013

Your gut has tastebuds, too!

We discovered that the gut can actually “taste” nutrients, sparking a new wave of insights into how digestion and appetite are controlled.

2016

Elcella's namesake - the L-Cells!

Attention turned to L-Cells, special cells in the gut that release appetite-regulating hormones whenever they sense nutrients. These would later inspire Elcella’s name.

2017

EUREKA!

We discovered that L-cells respond especially strongly to two specific nutrient types, releasing up to 2.5 times more of the fullness hormones GLP-1 and PYY.

2019

We tested Elcella on people

In our first clinical trial with obese volunteers, we saw a 13% reduction in food intake and increased PYY levels - an exciting validation of our research.

2022

We perfected the formula

Years of testing allowed us to refine the formulation for both safety and effectiveness, ensuring consistent results.

2023

We perfected the final formula

Our product was further validated in a clinical trial confirming that the formula boosted PYY and GLP-1 release while reducing food intake, reinforcing the scientific foundation.

2024

We made sure the dose was perfect

Further studies showed appetite responses are dose-dependent, allowing us to fine-tune Elcella with the precision usually seen in pharmaceuticals.

TODAY

Elcella made its way to you!

After more than a decade of research, Elcella is here: a science-backed way to support appetite control by working with your body’s own biology.

FAQ

Still have questions? We’re here to help! Email us at hello@elcella.com, and we’ll get back to you as soon as possible.

Our customer support is available Monday to Friday: 9am-5pm.Average answer time: 24h

Our discoveries are validated by the scientific community.

The cutting-edge science behind our approach is supported by peer-reviewed studies, published in top international research journals.

British Journal of Pharmacology, 2024

GPR84 In Physiology - Many functions in many tissues

Gut, 2022

Decoy bypass for appetite suppression in obese adults: role of synergistic nutrient sensing receptors GPR84 and FFAR4 on colonic endocrine cells

Nutrients, 2018

Effect of Obesity on the Expression of Nutrient Receptors and Satiety Hormones in the Human Colon

British Journal of Pharmacology, 2012

Peripheral neural targets in obesity